Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer
Becky A S Bibby, Niluja Thiruthaneeswaran, Lingjian Yang, Ronnie R Pereira, Elisabet More, Darragh G McArt, Paul O'Reilly, Robert G Bristow, Kaye J Williams, Ananya Choudhury, Catharine M L West
Dive into the research topics of 'Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer'. Together they form a unique fingerprint.